Source link : https://newshealth.biz/health-news/trial-patient-dies-after-receiving-crispr-gene-therapy/
(MedPage Today) — A patient with transthyretin amyloidosis (ATTR) who received the investigational gene therapy nexiguran ziclumeran (nex-z) in a phase III trial died, Intellia Therapeutics said. The news came days after the company paused the… Source link : https://www.medpagetoday.com/cardiology/generalcardiology/118385 Author : Publish date : 2025-11-07 22:28:00 Copyright for syndicated content belongs to the linked […]
The post Trial Patient Dies After Receiving CRISPR Gene Therapy first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-07 22:28:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8